Skip to content

13F-HR filed by Palo Alto Investors LP

Palo Alto Investors LP filed this 13F-HR for the quarter ended 2013-09-30, filed 2013-11-13, with 33 holding rows worth $952,498,000.

Accession
0001140361-13-042137
Filed
2013-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2013

A holdings report, 33 entries on the cover page, a total value of $952,498,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $952,498,000 with VALUE read as thousands by filing date, 13F file number 028-11013. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VIROPHARMA INC928241108COMMON STOCK3,093,291$121,443,000thousands by filing date
CYBERONICS23251P102COMMON STOCK1,919,518$97,396,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock1,063,442$83,852,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK4,563,520$83,056,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM1,014,611$64,479,000thousands by filing date
INTERMUNE INC45884X103COM3,595,756$55,303,000thousands by filing date
ABIOMED INC003654100COM2,654,347$50,592,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock3,211,318$43,481,000thousands by filing date
ONYX PHARMACEUTICALS INC683399109COM343,473$42,831,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM564,287$40,725,000thousands by filing date
QUESTCOR PHARMACEUTICALS INC74835Y101COM655,997$38,048,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM1,715,377$36,836,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM2,908,314$31,846,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK6,299,664$22,553,000thousands by filing date
SEQUENOM INC COM NEW817337405COM8,202,254$21,900,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM1,600,178$16,994,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM1,136,676$16,357,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM319,113$14,548,000thousands by filing date
ALIMERA SCIENCES INC016259103COM3,634,984$13,668,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM4,622,230$10,724,000thousands by filing date
QLT INC746927102COMMON STOCK2,052,411$9,503,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock779,876$9,203,000thousands by filing date
AVEO PHARMACEUTICALS INC053588109COM3,509,205$7,229,000thousands by filing date
SAVIENT PHARMACEUTICALS INC80517Q100COM8,752,981$5,465,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock266,299$4,157,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM395,985$3,318,000thousands by filing date
CYTOKINETICS INC23282W100CMN261,544$1,980,000thousands by filing date
XOMA CORP DEL98419J107COM418,183$1,878,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock88,500$1,790,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK44,129$581,000thousands by filing date
CELGENE CORP151020104COM1,690$260,000thousands by filing date
SOPHIRIS BIO INC F83578Q209FOREIGN CANADIAN55,000$257,000thousands by filing date
ALIGN TECHNOLOGY INC162551014COM5,088$245,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-13-042137this filing2013-11-13acceptance time not in the bulk data set
13F-HR/A 0001140361-13-043590 base2013-11-20acceptance time not in the bulk data set